In turn, a higher expression of ACE2 may also counteract oxidative stress and inflammation through the role of the receptor in the renin–angiotensin system (RAS) [24,25], although the significance of this anti-inflammatory mechanism on COVID-19 severity is not well supported by clinical data. This evidence concerns the gene ACE2 and COVID-19.